Tumor-infiltrating lymphocytes (TILs) isolated from p53-mutant tumors have been shown to recognize mutant p53 as a neoantigen, suggesting that mutant p53 is immunogenic [20,95]. This evidence concerns the gene TP53 and neoplasm.